Zydus In-Licensees Enoxaparin In US As It Plots $250m Injectables Business
Struck License And Supply Agreement With Italfarmaco Group’s Chemi
Zydus Cadila has partnered with an Italian manufacturer to launch a generic version of preservative free Lovenox. Days earlier, the Indian firm’s management had discussed its hopes and expectations for its fledgling US injectables business.
You may also be interested in...
Zydus Cadila’s single-dose nelarabine injection (250mg/50ml) will enjoy 180 days of competitive generic therapy market exclusivity following approval from the US FDA, as the first approved rival to Novartis’ Arranon brand.
Seattle biotech raised $36m series A in March, now obtains glaucoma and AMD drug candidates along with delivery technology. Alligator, Orion partner on bispecific antibodies for cancer.
Momenta and Sandoz must hand over $120m between them to a range of enoxaparin purchasers following final approval of a settlement agreement resolving claims the pair unfairly conspired to block further generic competition in the US to Sanofi’s Lovenox blood-thinner.